Carolinas Wealth Consulting’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-252
Closed -$1.45K 1116
2023
Q2
$1.45K Buy
252
+3
+1% +$18 ﹤0.01% 856
2023
Q1
$1.55K Sell
249
-61
-20% -$411 ﹤0.01% 841
2022
Q4
$2.09K Buy
310
+2
+0.6% +$14 ﹤0.01% 802
2022
Q3
$2K Buy
308
+2
+0.7% +$16 ﹤0.01% 782
2022
Q2
$2K Hold
306
﹤0.01% 783
2022
Q1
$4K Hold
306
﹤0.01% 739
2021
Q4
$4K Buy
306
+1
+0.3% +$13 ﹤0.01% 748
2021
Q3
$4K Buy
305
+5
+2% +$79 ﹤0.01% 716
2021
Q2
$6K Buy
300
+1
+0.3% +$18 ﹤0.01% 684
2021
Q1
$6K Buy
299
+2
+0.7% +$40 ﹤0.01% 689
2020
Q4
$4K Buy
297
+4
+1% +$53 ﹤0.01% 682
2020
Q3
$3K Buy
293
+5
+2% +$61 ﹤0.01% 659
2020
Q2
$4K Buy
+288
New +$3.38K ﹤0.01% 430

Other funds holding TOKE

Carolinas Wealth Consulting's TOKE Position: Q3 2023 in Review

Carolinas Wealth Consulting sold out of Cambria Cannabis ETF (TOKE) in Q3 2023, closing a stake of 252 shares — an estimated $1.45K sold.

Carolinas Wealth Consulting first reported a position in TOKE in Q2 2020 and held it in 13 quarters. The position peaked at $6K in Q2 2021. 19 funds tracked by Wall St. Rank hold TOKE as of Q3 2023.

  • Carolinas Wealth Consulting reported no remaining Cambria Cannabis ETF position as of Q3 2023 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 252 Cambria Cannabis ETF shares in Q3 2023, an estimated $1.45K.
  • Carolinas Wealth Consulting first reported a position in Cambria Cannabis ETF in Q2 2020 and held it in 13 quarters.
  • Carolinas Wealth Consulting's Cambria Cannabis ETF position peaked at $6K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q3 2023.

Based on Carolinas Wealth Consulting's 13F filing for Q3 2023, filed 14 Nov 2023.